This work aimed to investigate the effects on performance and carcass characteristics of broiler chickens of 2 levels of guanidino acetic acid (GAA) in a commercial form (CreAMINO®) and 4 levels of metabolisable energy. The eight dietary regimens were tested for starter (0-10 d), grower (11-22 d) and finisher (23-35 d) peri ods on a total of 200 male ROSS 308 broiler chickens in a factorial arrangements of treat ments (2 4), with experimental diet fed to 5 replicate pens with 4 birds each. The results revealed a positive effect for CreAMINO® supplementation on feed conversion ratio (FCR) for the starter, grower, finisher and cumulative periods (P<0.05, 0.05, 0.01 and 0.001, respectively); feed conversion was significantly improved in the treatment with CreAMINO® supplementation vs unsupplemented group. During the grower period, a significant difference in FCR was observed for metabolisable energy (ME) level (P<0.01). When examining the cumulative period of the trial (0 to 35 days of age), two-way interaction was significant for feed intake and body weight gain. Birds receiving the control level of energy, 75 or 50 kcal/kg lower ME than the control, consumed less feed when supplemented with CreAMINO®. Birds receiving 25 kcal/kg lower ME or the control energy levels gained more weight when supplemented with CreAMINO®. In summary, GAA (as CreAMINO) improved FCR of broilers in each period as well as cumulatively, while ME level also affected FCR. CreAMINO® supplementation to reduced-energy diets showed FCR improvements, while the best performance was detected for the diet with 50 kcal/kg lower ME.
No takes yet. Share an insight, caveat, or question.
Abudabos et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: